MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
2026: Medtech Big 100: The world’s largest medical device companies
Johnson & Johnson, Inc. [J&J] (NYSE:JNJ)*
Finance & Acquisition: Johnson & Johnson (J&J)
Parents
Johnson & Johnson, Inc. [J&J] (NYSE:JNJ)*
Children
2011: Pharmacyclics Inc Could Get $975 Million in J&J License Deal (2011)
2012: J&J gains EU nod for $21.3B Synthes deal (2012)
2014: Carlyle to Buy J&J’s Blood Test Unit for $4 Billion (2014)
2014: Inspire’s recent round attracted several new investors, including New York-based OrbiMed Advisors, Johnson & Johnson’s venture capital arm and Aperture Venture Partners.
2014: Powervision's Series D funding included Venrock, Johnson & Johnson Development Corp., Medtronic, Advanced Technology Ventures, Lexington Capital and Frazier Healthcare Ventures.
2015: 2. J&J Medical Device Segment: 28.9% Profit Margin
2015: J&J confirms $1.9B sale of Cordis unit to Cardinal Health, ending months of speculation
2015: J&J readies to rid itself of Cordis--for as much as $2B to Cardinal Health
2016: Abbott Selling Optics Biz to J&J for $4 Billion
2016: Johnson & Johnson has rolled out a crowdfunding website to support global public health initiatives
2017: Ethicon, Johnson & Johnson, Announces Agreement To Acquire NeuWave Medical, Inc.
2017: J&J buys 3D-printing tech to create bone-healing implants
2017: Johnson & Johnson seals biggest European pharma deal in 13 years as it snaps up Actelion
2017: What You Need To Know About The JNJ Deal for Actelion - Johnson & Johnson (NYSE:JNJ)
2018: J&J antes up on a $1B gamble that Theravance has the next blockbuster JAK for Crohn’s, ulcerative colitis – Endpoints News
2018: Montgomery County, Maryland-based BeneVir Biopharm, Inc. to be acquired by Janssen Biotech, Inc. for up to $1.04B_Biohealth Innovation
2018: Theravance Biopharma: Johnson & Johnson Deal Looks Solid - Theravance Biopharma, Inc. (NASDAQ:TBPH)
2019: Here Is What's Surprising About J&J's $3.4 B Robotic Surgery Buyout of Auris_www.investors.com
2019: J&J eying surgical robotics firm Auris Health: Bloomberg
2019: Johnson & Johnson Invites Applications for QuickFire Challenge in Oncology
2019: Veracyte Finds Ally in J&J for Early Lung Cancer Detection
2020: J&J buys an early-stage gene therapy for the eye
2020: J&J inks industry's latest bolt-on buyout with $6.5B deal to acquire Momenta, beefing up its autoimmune pipeline
2020: Legend Biotech_BCMA rival to bluebird, Bristol Myers files for $100M IPO as the frontrunners stumble in a race to the finish line – Endpoints News
2020: Why Johnson & Johnson is investing in this niche telehealth startup
2021: J&J sets out to split the world's largest healthcare conglomerate, hiving off the consumer division
2021: Johnson & Johnson Innovation Invites Applications for Decoding Disparities QuickFire Challenge
2021: Johnson & Johnson Innovation Invites Applications for Projects to Address Healthcare Needs of Veterans
2021: Johnson & Johnson Invites Proposals for Nurse-Led Mental Health Care Ideas
2022: J&J to buy heart pump maker Abiomed in $16.6 bln deal
2022: Janssen J&J launches initiative to address peripheral artery disease
2022: Johnson & Johnson (J&J) Vets QuickFire Challenge: Lung Cancer & Physical Trauma.
2022: Johnson & Johnson Innovation invites applications for health equity solutions
2022: Johnson & Johnson Innovation Invites Applications for Healthcare Transformation Through Nurse-led Tech QuickFire Challenge
2022: Johnson & Johnson Innovation Invites Applications for Immunology Innovations QuickFire Challenge
2023: Innovation invites applications for Global Health Discovery QuickFire Challenge: Flavivirus Infections
2023: J&J, ASPR, BARDA_BLUE KNIGHT QuickPitch: Activating for the Future_ Innovation Centers
2023: Johnson & Johnson: An Update Following The Kenvue IPO_ seekingalpha.com
2023: Laminar, Inc. Acquired by Johnson & Johnson Medtech for $400 Million Upfront with Additional Clinical and Regulatory Milestone Payments in 2024 and Beyond
2024: Ambrx Announces Sale to Johnson & Johnson
2024: J&J to recognize $1.25B impact from Yellow Jersey acquisition
2024: Johnson & Johnson 2023 Q4 - Results - Earnings Call Presentation
2024: Johnson & Johnson Ends The Shockwave Rumor Mill With $13.1 Billion Takeover
2024: Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
2025: J&J MedTech's global head of digital wants to fund your AI project
2025: J&J to buy psychiatric drug developer Intra-Cellular for $14.6B
2025: Johnson & Johnson 2024 Q4 - Results - Earnings Call Presentation
2025: Johnson & Johnson Dips On Q4 Earnings: Here's What The Market Isn't Seeing
2025: Johnson & Johnson Launches Polyphonic AI Fund for Surgery
2025: Johnson & Johnson set to revolutionize the treatment of cancer with the acquisition of Halda Therapeutics
2025: Johnson & Johnson’s corporate venture capital organization, JJDC, led the financing. Lilly Asia Ventures, INCE Capital and Granite Asia also participated in the round.
2025: Ronovo Surgical raises $67M for surgical robot, inks J&J collab
2025: What Johnson & Johnson Is Getting With The Acquisition Of Intra-Cellular Therapies
Abiomed Inc. (Nasdaq: ABMD)
Acclarent
Actelion Ltd
Acuity
Ambrx Biopharma Inc (NASDAQ: AMAM)
Animas Corporation, Johnson & Johnson
Aragon Pharmaceuticals
Arstasis
Auris Health, Inc. , formerly, Auris Surgical Robotics
BAS Medical
BeneVir Biopharm Inc
BioRexis Pharmaceuticals Corp
Biosense Webster, a Johnson & Johnson Company
CardioPolymers, formerly, Symphony Medical
Centocor Ortho Biotech, a unit of Johnson & Johnson
COSAT-Corporate Office of Science and Technology, J&J
Covagen
Crucell
Gynecare, Inc
HALDA THERAPEUTICS INC.
HealthMedia Inc
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)*
IntraPace, Inc-TEDCO
Johnson & Johnson Development Corporation (JJDC)
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JLABS (JLABS)
Laminar, Inc.
Menlo Care
Micrus Endovascular
Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA)
NeuWave Medical
Omrix Biopharmaceuticals
OraPharma, Inc
Othera Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc
Proteologix, Inc
ShockWave Medical, Inc. (NASDAQ:SWAV)*
Spinal Modulation
Synthes, Inc: #21. Medical Devices, $3.4B (2009)
Taris Biomedical
Tengion (TNGN)
TranMolecular
UltraCision
V-Wave
Vascular Control Systems
Veridex, LLC
Yellow Jersey Therapeutics
Zosano Pharma (NASDAQ:ZSAN), formerly, Macroflux
Jumps
**Key People: Johnson & Johnson (J&J)
Organization & Developments: Johnson & Johnson (J&J)